細胞溶解/細胞分画市場：製品タイプ、細胞タイプ、用途、エンドユーザー別-2025-2030年世界予測

細胞溶解/細胞分画市場は、2023年に33億5,000万米ドルと評価され、2024年には36億3,000万米ドルに達すると予測され、CAGR 8.55%で成長し、2030年には59億5,000万米ドルに達すると予測されています。

細胞溶解と細胞分画は、分子生物学と生化学において重要な技術であり、さらなる分析のために細胞成分を分離するために不可欠です。これらのプロセスにより、科学者は細胞を破砕し（溶解）、その内部成分を分離し（分画）、タンパク質、核酸、その他の分子の研究を容易にします。これらの技術の必要性は、研究、医薬品、診断において広く応用され、病気の理解、医薬品開発、治療法の進歩を可能にすることから生じています。最終用途の範囲は広く、バイオテクノロジー企業、研究所、臨床用途、個別化医療やゲノミクスに重点を置く産業に及んでいます。市場成長は、研究開発投資の増加、機器の技術的進歩、新規治療を必要とする慢性疾患の有病率の上昇の影響を受けています。細胞分析の精度と効率を高める自動化された使いやすい装置の開発には機会があふれています。データ解析のためのAIと機械学習の統合は、壊れやすい生体分子を保護するためのより穏やかな細胞溶解のための新規技術の探求と同様に、有望なフロンティアを提示しています。しかし、この市場は、高い運用コストや、細胞の完全性の維持や汚染のリスクに関する技術的課題などの限界に直面しています。バイオテクノロジーにおける知的財産の問題や厳しい規制基準が、さらにハードルを高めています。チャンスをつかむための提言としては、プロセスの複雑さとコストを削減する技術革新への投資、方法と材料における持続可能性の重視などがあります。学術機関とバイオテクノロジー企業の協力的パートナーシップは、新しい方法の統合を加速することができます。イノベーションはまた、資源が限られた環境でますます価値が高まるポイント・オブ・ケア・アプリケーションに対応するため、小型化とラボオンチップ技術に焦点を当てるべきです。全体として、この市場はダイナミックではあるが課題的であり、その複雑さを戦略的に乗り切る者には大きな可能性があると見られています。

市場力学：急速に進化する細胞溶解/細胞分画市場の主要市場インサイトを公開

細胞溶解/細胞分画市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • ヘルスケア、ライフサイエンス、製薬産業の拡大
  • ライフサイエンス分野の研究に対する政府資金の増加
  • HIV/AIDSやがんなどの疾病の流行拡大
• 市場抑制要因
  • 細胞ベースの機器と調査費用の高騰
• 市場機会
  • 個別化医療への関心の高まりとバイオ医薬品・バイオテクノロジー産業の拡大
  • 医療機関における活発な調査活動
• 市場の課題
  • 細胞溶解/細胞分画の訓練を受けた人材の不足

ポーターの5つの力：細胞溶解/細胞分画市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、細胞溶解/細胞分画市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：細胞溶解/細胞分画市場における外部からの影響の把握

外部マクロ環境要因は、細胞溶解/細胞分画市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析細胞溶解/細胞分画市場における競合情勢の把握

細胞溶解/細胞分画市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス細胞溶解/細胞分画市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、細胞溶解/細胞分画市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨細胞溶解/細胞分画市場における成功への道筋を描く

細胞溶解/細胞分画市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 拡大するヘルスケア、ライフサイエンス、製薬業界
    • 生命科学調査への政府資金の増額
    • HIV/エイズやがんなどの病気の蔓延が増加
  • 抑制要因
    • 細胞ベースの機器と調査の高コスト
  • 機会
    • 個別化医療への注目の高まりとバイオ医薬品およびバイオテクノロジー産業の拡大
    • 医療機関を横断した強力な細胞溶解/細胞分画調査活動
  • 課題
    • 細胞溶解/細胞分画の訓練を受けた人材が不足している
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 細胞溶解/細胞分画市場：製品別

• 消耗品
  • ビーズ
  • 使い捨て
  • 試薬とキット
• 機器
  • ホモジナイザー
  • ソニケーター

第7章 細胞溶解/細胞分画市場細胞の種類別

• 哺乳類細胞
• 微生物細胞

第8章 細胞溶解/細胞分画市場：用途別

• 核酸の精製と分離
• タンパク質の精製と分離

第9章 細胞溶解/細胞分画市場：エンドユーザー別

• バイオ医薬品・バイオテクノロジー企業
• 調査室・研究所

第10章 南北アメリカの細胞溶解/細胞分画市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の細胞溶解/細胞分画市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの細胞溶解/細胞分画市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abcam PLC
• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Cell Signaling Technology, Inc.
• Claremont BioSolutions, LLC
• Covaris, LLC
• Creative Biostructure
• F. Hoffmann-La Roche Ltd.
• Geno Technology Inc.
• Invent Biotechnologies, Inc.
• Merck KGaA
• Microfluidics International Corporation by IDEX Corporation
• Miltenyi Biotec B.V. & Co. KG
• Norgen Biotek Corp.
• NZYTech, Lda.
• Parr Instrument Company
• Promega Corporation
• PromoCell GmbH
• Qiagen NV
• Qsonica L.L.C
• STEMCELL Technologies Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. CELL LYSIS/CELL FRACTIONATION MARKET RESEARCH PROCESS
• FIGURE 2. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL LYSIS/CELL FRACTIONATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CELL LYSIS/CELL FRACTIONATION MARKET DYNAMICS
• TABLE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 47. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 150. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 188. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 189. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 190. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 212. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 213. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 214. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 218. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 219. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 220. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 253. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 258. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 264. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 276. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 277. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023

The Cell Lysis/Cell Fractionation Market was valued at USD 3.35 billion in 2023, expected to reach USD 3.63 billion in 2024, and is projected to grow at a CAGR of 8.55%, to USD 5.95 billion by 2030.

Cell lysis and cell fractionation are vital techniques in molecular biology and biochemistry, essential for isolating cellular components for further analysis. These processes allow scientists to break open cells (lysis) and separate their internal constituents (fractionation), thereby facilitating the study of proteins, nucleic acids, and other molecules. The necessity of these techniques arises from their widespread application in research, pharmaceuticals, and diagnostics, enabling advancements in disease understanding, drug development, and therapeutic solutions. The end-use scope is expansive, spanning biotechnology firms, research labs, clinical applications, and industries focused on personalized medicine and genomics. Market growth is influenced by increased R&D investments, technological advancements in equipment, and the rising prevalence of chronic diseases necessitating novel treatments. Opportunities abound in developing automated, user-friendly equipment that enhances precision and efficiency in cell analysis. The integration of AI and machine learning for data analysis presents a promising frontier, as does exploring novel techniques for gentler cell lysis to protect fragile biomolecules. However, the market faces limitations such as high operational costs and technical challenges related to preserving cell integrity and the risk of contamination. Intellectual property issues and strict regulatory standards in biotechnology add further hurdles. Recommendations for seizing opportunities include investing in innovations that reduce process complexity and cost, and emphasizing sustainability in methods and materials. Collaborative partnerships between academic institutions and biotech firms can accelerate the integration of new methods. Innovations should also focus on miniaturization and lab-on-a-chip technologies to cater to point-of-care applications, which are increasingly valuable in resource-limited settings. Overall, the market is seen as dynamic but challenging, with significant potential for those who navigate its complexities strategically.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Lysis/Cell Fractionation Market

The Cell Lysis/Cell Fractionation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expanding healthcare, life sciences, and pharmaceutical industries
  • Increasing government funding for research in life sciences
  • Growing prevalence of diseases such as HIV/AIDS and cancer
• Market Restraints
  • High cost of cell-based equipment and research
• Market Opportunities
  • Growing focus on personalized medicine and the expansion of biopharmaceutical and biotechnology industries
  • Robust cell lysis/cell fractionation research activities across medical institutes
• Market Challenges
  • Shortage of trained personnel for cell lysis/cell fractionation

Porter's Five Forces: A Strategic Tool for Navigating the Cell Lysis/Cell Fractionation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Lysis/Cell Fractionation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Lysis/Cell Fractionation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Lysis/Cell Fractionation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Lysis/Cell Fractionation Market

A detailed market share analysis in the Cell Lysis/Cell Fractionation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Lysis/Cell Fractionation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Lysis/Cell Fractionation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Lysis/Cell Fractionation Market

A strategic analysis of the Cell Lysis/Cell Fractionation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Lysis/Cell Fractionation Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Claremont BioSolutions, LLC, Covaris, LLC, Creative Biostructure, F. Hoffmann-La Roche Ltd., Geno Technology Inc., Invent Biotechnologies, Inc., Merck KGaA, Microfluidics International Corporation by IDEX Corporation, Miltenyi Biotec B.V. & Co. KG, Norgen Biotek Corp., NZYTech, Lda., Parr Instrument Company, Promega Corporation, PromoCell GmbH, Qiagen NV, Qsonica L.L.C, STEMCELL Technologies Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Lysis/Cell Fractionation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Beads, Disposables, and Reagents & Kits. The Instruments is further studied across Homogenizers and Sonicators.
• Based on Cell Type, market is studied across Mammalian Cells and Microbial Cells.
• Based on Application, market is studied across Nucleic Acid Purification & Isolation and Protein Purification & Isolation.
• Based on End-User, market is studied across Biopharmaceutical & Biotechnology Companies and Research Laboratories & Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries
    • 5.1.1.2. Increasing government funding for research in life sciences
    • 5.1.1.3. Growing prevalence of diseases such as HIV/AIDS and cancer
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of cell-based equipment and research
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing focus on personalized medicine and the expansion of biopharmaceutical and biotechnology industries
    • 5.1.3.2. Robust cell lysis/cell fractionation research activities across medical institutes
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of trained personnel for cell lysis/cell fractionation
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell Lysis/Cell Fractionation Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Beads
  • 6.2.2. Disposables
  • 6.2.3. Reagents & Kits
• 6.3. Instruments
  • 6.3.1. Homogenizers
  • 6.3.2. Sonicators

7. Cell Lysis/Cell Fractionation Market, by Cell Type

• 7.1. Introduction
• 7.2. Mammalian Cells
• 7.3. Microbial Cells

8. Cell Lysis/Cell Fractionation Market, by Application

• 8.1. Introduction
• 8.2. Nucleic Acid Purification & Isolation
• 8.3. Protein Purification & Isolation

9. Cell Lysis/Cell Fractionation Market, by End-User

• 9.1. Introduction
• 9.2. Biopharmaceutical & Biotechnology Companies
• 9.3. Research Laboratories & Institutes

10. Americas Cell Lysis/Cell Fractionation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Lysis/Cell Fractionation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. Agilent Technologies, Inc.
• 3. Beckman Coulter, Inc.
• 4. Becton, Dickinson and Company
• 5. Bio-Rad Laboratories, Inc.
• 6. Cell Signaling Technology, Inc.
• 7. Claremont BioSolutions, LLC
• 8. Covaris, LLC
• 9. Creative Biostructure
• 10. F. Hoffmann-La Roche Ltd.
• 11. Geno Technology Inc.
• 12. Invent Biotechnologies, Inc.
• 13. Merck KGaA
• 14. Microfluidics International Corporation by IDEX Corporation
• 15. Miltenyi Biotec B.V. & Co. KG
• 16. Norgen Biotek Corp.
• 17. NZYTech, Lda.
• 18. Parr Instrument Company
• 19. Promega Corporation
• 20. PromoCell GmbH
• 21. Qiagen NV
• 22. Qsonica L.L.C
• 23. STEMCELL Technologies Inc.
• 24. Takara Bio Inc.
• 25. Thermo Fisher Scientific Inc.